REQUEST A DEMO
Total
USD $0.00
Search more companies

Medical Supplies & Services Zomac S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medical Supplies & Services Zomac S.A.S. Profile Updated: November 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Medical Supplies & Services Zomac S.A.S. is based in Colombia. The head office is in Tello. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on April 05, 2018. There was a net sales revenue increase of 208.85% reported in Medical Supplies & Services Zomac S.A.S.’s latest financial highlights for 2022. Over the same period, its total assets grew by 36.15%. The enterprise’s net profit margin decreased by 28.89% in 2022.

Headquarters
Cl 4 5 67 - Centro
Tello; Huila;

Contact Details: Purchase the Medical Supplies & Services Zomac S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medical Supplies & Services Zomac S.A.S. report to view the information.
Incorporation Date:
April 05, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Medical Supplies & Services Zomac S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
208.85%
Total operating revenue
207.23%
Operating profit (EBIT)
-14.52%
Net Profit (Loss) for the Period
-35.98%
Total assets
36.15%
Total equity
17.58%
Operating Profit Margin (ROS)
-27.24%
Net Profit Margin
-28.89%
Return on Equity (ROE)
-12.52%
Debt to Equity Ratio
5.9%
Quick Ratio
-0.32%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?